Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia

被引：1

作者：

Alexopoulos, Panagiotis ^{[1
,2
]}

Thierjung, Nathalie ^{[1
]}

Economou, Polychronis ^{[3
]}

Werle, Lukas ^{[1
,4
]}

Buhl, Felix ^{[1
]}

Kagerbauer, Simone ^{[5
]}

Papanastasiou, Anastasios D. ^{[6
]}

Grimmer, Timo ^{[1
]}

Gourzis, Philippos ^{[2
]}

Berthele, Achim ^{[7
]}

Hemmer, Bernhard ^{[7
,8
]}

Kuebler, Hubert ^{[9
]}

Martin, Jan ^{[5
]}

Politis, Antonios ^{[10
,11
]}

Perneczky, Robert ^{[8
,12
,13
,14
]}

机构：

[1] Tech Univ Munich, Dept Psychiat & Psychotherapy, Klinikum Rechts Isar, Munich, Germany

[2] Univ Patras, Univ Hosp Rion, Dept Psychiat, Patras, Greece

[3] Univ Patras, Dept Civil Engn Stat, Patras, Greece

[4] Max Planck Inst Psychiat, Munich, Germany

[5] Tech Univ Munich, Dept Anaesthesiol, Klinikum Rechts Isar, Munich, Germany

[6] Univ Patras, Mol Oncol Lab, Div Oncol, Univ Hosp Patras, Patras, Greece

[7] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany

[8] Munich Cluster Syst Neurol SyNergy, Munich, Germany

[9] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Munich, Germany

[10] Univ Athens, Dept Psychiat 1, Eginit Hosp, Athens, Greece

[11] Johns Hopkins Med Sch, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD USA

[12] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Munich, Germany

[13] Imperial Coll Sci Technol & Med, Ageing Epidemiol AGE Res Unit, Sch Publ Hlth, Fac Med, London, England

[14] German Ctr Neurodegenerat Dis DZNE Munich, Munich, Germany

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2019年 / 69卷 / 01期

关键词：

Biomarker candidate; NIA-AA research framework diagnostic criteria; soluble amyloid-beta protein precursor beta; CEREBROSPINAL-FLUID BIOMARKERS; AMYLOID PRECURSOR PROTEINS; MILD COGNITIVE IMPAIRMENT; BACE1; ACTIVITY; CSF; BETA-AMYLOID((1-42)); METABOLISM; CLEARANCE; DECLINE; MARKERS;

D O I：

10.3233/JAD-181088

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Cost- and time-effective markers of Alzheimer's disease (AD), reliable and feasible at the population level are urgently needed. Soluble amyloid-beta protein precursor beta (sA beta PP beta) in plasma has attracted scientific attention as a potential AD biomarker candidate. Here we report that plasma sA beta PP beta levels in patients with AD dementia and typical for AD cerebrospinal fluid (CSF) biomarker profiles (N = 33) are significantly lower (p < 0.01) than those of cognitively healthy elderly individuals without AD (N = 39), while CSF sA beta PP beta levels did not differ between the studied groups. This provides further evidence for the potential of sA beta PP beta in plasma as an AD biomarker candidate.

引用

页码：83 / 90

页数：8

共 50 条

[1] Plasma Viscosity: Is a Biomarker for the Differential Diagnosis of Alzheimer's Disease and Vascular Dementia?
Aras, Sevgi
Tek, Ibrahim
Varli, Murat
Yalcin, Ahmet
Cengiz, Ozlem Karaarslan
Atmis, Volkan
Atli, Teslime
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2013, 28 (01): : 62 - 68
[2] Potential Utility of Soluble p3-Alcadeinα Plasma Levels as a Biomarker for Sporadic Alzheimer's Disease
Kamogawa, Kenji
Kohara, Katsuhiko
Tabara, Yasuharu
Takita, Rie
Miki, Tetsuro
Konno, Tomoko
Hata, Saori
Suzuki, Toshiharu
JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (02) : 421 - 428
[3] Plasma soluble neuregulin-1 as a diagnostic biomarker for Alzheimer's disease
Chang, Keun-A
Shin, Ki Young
Nam, Eunjoo
Lee, Yeong-Bae
Moon, Cheil
Suh, Yoo-Hun
Lee, Sang Hyung
NEUROCHEMISTRY INTERNATIONAL, 2016, 97 : 1 - 7
[4] Low levels of plasma antioxidants in Alzheimer's disease and vascular dementia
Shim, Y. S.
Lee, Y. B.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 283 (1-2) : 281 - 281
[5] Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk
Dark, Heather E.
Paterson, Clare
Daya, Gulzar N.
Peng, Zhongsheng
Duggan, Michael R.
Bilgel, Murat
An, Yang
Moghekar, Abhay
Davatzikos, Christos
Resnick, Susan M.
Loupy, Kelsey
Simpson, Missy
Candia, Julian
Mosley, Thomas
Coresh, Josef
Palta, Priya
Ferrucci, Luigi
Shapiro, Allison
Williams, Stephen A.
Walker, Keenan A.
ANNALS OF NEUROLOGY, 2024, 95 (02) : 260 - 273
[6] Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease
Alexopoulos, Panagiotis
Gleixner, Lena-Sophie
Werle, Lukas
Buhl, Felix
Thierjung, Nathalie
Giourou, Evangelia
Kagerbauer, Simone M.
Gourzis, Philippos
Kuebler, Hubert
Grimmer, Timo
Yakushev, Igor
Martin, Jan
Kurz, Alexander
Perneczky, Robert
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2018, 268 (05) : 519 - 524
[7] Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease
Panagiotis Alexopoulos
Lena-Sophie Gleixner
Lukas Werle
Felix Buhl
Nathalie Thierjung
Evangelia Giourou
Simone M. Kagerbauer
Philippos Gourzis
Hubert Kübler
Timo Grimmer
Igor Yakushev
Jan Martin
Alexander Kurz
Robert Perneczky
European Archives of Psychiatry and Clinical Neuroscience, 2018, 268 : 519 - 524
[8] Determinants of Plasma Alzheimer's Disease Biomarker Use by Primary Care Providers and Dementia Specialists
O'Brien, Kyra
Coykendall, Cameron
Kleid, Melanie
Harkins, Kristin
Chin, Nathaniel
Clapp, Justin T.
Karlawish, Jason
JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (04) : 652 - 660
[9] 3α,5α-THP:: a potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia
Smith, Charles D.
Wekstein, David R.
Markesbery, William R.
Frye, Cheryl A.
PSYCHOPHARMACOLOGY, 2006, 186 (03) : 481 - 485
[10] Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia
Delaby, Constance
Alcolea, Daniel
Busto, Germain
Gabelle, Audrey
Ayrignac, Xavier
Bennys, Karim
Muino, Elena
Villatoro, Paula
Fernandez-Cadenas, Israel
Pradeilles, Nicolas
El Bounasri, Shaima
Torres, Soraya
Hirtz, Christophe
Zetterberg, Henrik
Lleo, Alberto
Fortea, Juan
Lehmann, Sylvain
ALZHEIMERS RESEARCH & THERAPY, 2025, 17 (01)

← 1 2 3 4 5 →